Zacks Investment Research
15 Aug 2026, 00:46 UTC · 3h ago
This Dividend Aristocrat Posted Record Quarterly Results
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
15 Aug 2026, 00:46 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Johnson & Johnson raised its sales and adjusted EPS guidance for the current fiscal year. — Upward revisions to both top and bottom line guidance typically trigger positive price action and signal strong operational momentum.
+0.60Johnson & Johnson is on track to exceed $100 billion in annual revenue for the first time in its history in 2026. — Achieving a historic revenue milestone indicates significant scale growth and market share expansion.
+0.40Johnson & Johnson reported record quarterly sales of $25.3 billion, representing a 6.6% year-over-year increase. — Record sales confirm organic growth and the efficacy of current business strategies.
+0.30Which stocks this story touches
Continue reading
6 related stories
Search tags
The company reported record quarterly sales, increased guidance, and is highlighted for its strong stock performance and dividend history.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
5h ago
